Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reveal recognition of hypertension as a critical health concern, exemplified by phrases like 'most important risk factor' and comments on its treatment cascade. The tone indicates respectful acknowledgment but limited depth, as posts mainly cite the publication and agree with its findings without extensive debate.
Most discussions acknowledge the importance of hypertension as a major health issue in India, reflecting consensus with the publication's focus.
The posts show some interest in the data and implications but are relatively moderate in enthusiasm.
Comments are somewhat surface-level, mentioning the study and its importance without deep analysis or critique.
While the discussions recognize hypertension's seriousness, they don't indicate widespread calls for policy change or significant action.
TW : 第33回インド高血圧学会学術大会に協賛: Hypertension: The most important non communicable disease risk factor in India. Indian Heart J. 2018;70(4):565-572. 4... Hypertension treatment cascade in India: results from National Noncommunicable Disease… https://t.co/uRUcEgK3rI
TW : プレスリリース：第33回インド高血圧学会学術大会に協賛（共同通信PRワイヤー） - 毎日新聞: Hypertension: The most important non communicable disease risk factor in India. Indian Heart J. 2018;70(4):565-572. 4... Hypertension treatment cascade in India:… https://t.co/6dQ1YYSTlx
Ajanta Pharma has announced the launch of Met XL AMT, a triple drug combination for hypertension management in India. Approved by DCGI, it combines Telmisartan, Amlodipine, and Metoprolol extended release to treat…
Veerado Pharmaceuticals, a leader in cardiology, launches Met XL AMT, a novel triple drug FDC for uncontrolled hypertension with cardiovascular comorbidities, approved by DCGI. This innovative combination aims to…
TW : 第33回インド高血圧学会学術大会に協賛: Hypertension: The most important non communicable disease risk factor in India. Indian Heart J. 2018;70(4):565-572. 4... Hypertension treatment cascade in India: results from National Noncommunicable Disease… https://t.co/uRUcEgK3rI
TW : プレスリリース：第33回インド高血圧学会学術大会に協賛（共同通信PRワイヤー） - 毎日新聞: Hypertension: The most important non communicable disease risk factor in India. Indian Heart J. 2018;70(4):565-572. 4... Hypertension treatment cascade in India:… https://t.co/6dQ1YYSTlx